Brand / Product	Market	Holder	Status	Expires
OMNIPOL 350 SOLUTION; INJECTION	🇿🇼Zimbabwe	WMT PHARMACEUTICALS PVT LTD	active	Dec 2027
OMNIPOL 300 SOLUTION; INJECTION	🇿🇼Zimbabwe	WMT PHARMACEUTICALS PVT LTD	active	Dec 2027
OMNIPAQUE TM 350 SOLUTION FOR INJECTION (Each ml contains Iohexol 350mg)	🇬🇭Ghana	—	active	Apr 2027
OMNIPAQUE TM 300 SOLUTION FOR INJECTION (Each ml contains Iohexol 300mg)	🇬🇭Ghana	—	active	Apr 2027
OMNIPAQUE TM 350 SOLUTION FOR INJECTION (Each ml contains Iohexol 350mg)	🇬🇭Ghana	—	active	Apr 2027
OMNIPAQUE TM 300 SOLUTION FOR INJECTION (Each ml contains Iohexol 300mg)	🇬🇭Ghana	—	active	Apr 2027
OMNIPAQUE 350MG SOLUTION INJECTABLE FLACON DE 100ML	🇨🇮Côte d'Ivoire	LABORATOIRE GE HEALTHCARE AS	expired	Jan 2025
OMNIPAQUE 300MG SOLUTION INJECTABLE FLACON DE 50ML	🇨🇮Côte d'Ivoire	LABORATOIRE GE HEALTHCARE AS	expired	Jan 2025
OMNIPAQUE 300MG SOLUTION INJECTABLE FLACON DE 100ML	🇨🇮Côte d'Ivoire	LABORATOIRE GE HEALTHCARE AS	expired	Jan 2025
OMNIPAQUE 350MG SOLUTION INJECTABLE FLACON DE 50ML	🇨🇮Côte d'Ivoire	LABORATOIRE GE HEALTHCARE AS	expired	Jan 2025
MEDISCAN Solution injectable / 300 mg /ml	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Aug 2023
MEDISCAN Solution injectable / 350 mg/ml	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Jul 2023
MEDISCAN Solution injectable / 350 mg/ml	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Jul 2023
MEDISCAN Solution injectable / 300mg /ml	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Jul 2023
XOPAQUE 350 Solution Injectable Intravasculaire / 350 mg/ml	🇹🇳Tunisia	DORCAS	expired	Apr 2021
OMNIPAQUE Solution injectable / 350 mg I/ml	🇹🇳Tunisia	GE HEALTHCARE AS NORVEGE	expired	Dec 2014
OMNIPAQUE Solution injectable / 350 mg I/ml	🇹🇳Tunisia	GE HEALTHCARE AS NORVEGE	expired	Dec 2014
OMNIPAQUE Solution injectable / 300 mg I/ml	🇹🇳Tunisia	GE HEALTHCARE AS NORVEGE	expired	Nov 2014
OMNIPAQUE Solution injectable / 300 mg I/ml	🇹🇳Tunisia	GE HEALTHCARE AS NORVEGE	expired	Apr 2003
OMNIPAQUE Solution injectable / 350 mg I/ml	🇹🇳Tunisia	GE HEALTHCARE AS NORVEGE	expired	Apr 2003
OMNIPAQUE solution injectable / 350 mg	🇸🇳Senegal	GE HEALTH CARE	active	—
Contrapaque Injection	🇹🇿Tanzania	UNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd)	active	—
Devhexol 350 Injection Solution for injection	🇳🇬Nigeria	—	active	—
IOHEXOL-M solution injectable / 300 mg	🇸🇳Senegal	MULTI-G BVBA LEEMSTRAAT 166 2018 ANTWERPEN, BELGIQUE	active	—
IOHEXOL PARENTERAL ORDINARY VIALS	🇺🇬Uganda	UNIQUE PHARMACEUTICA LS LABORATORIES	active	—
Iohexol 350 mg I/mL Solution for Injection Solution for injection	🇹🇿Tanzania	JEWAL PHARMACEUTICAL PRIVATE LIMITED	active	—
IOHEXOL PARENTERAL ORDINARY VIALS	🇺🇬Uganda	UNIQUE PHARMACEUTICA LS LABORATORIES	active	—
IOHEXO-M 350 MG SOLUTION INJECTABLE EN I.V FLACON DE 50 ML	🇨🇮Côte d'Ivoire	MULTI-G BVBA	active	—
IOXRAY 300 MG D'I/ML SOLUTION INJECTABLE, BOÎTE DE 1 FLACON DE 50 ML	🇨🇮Côte d'Ivoire	FRILAB SA	active	—
IOHEXO-M 300 MG SOLUTION INJECTABLE EN I.V FLACON DE 50 ML	🇨🇮Côte d'Ivoire	MULTI-G BVBA	active	—
IOHEXO-M solution injectable / 300mg	🇸🇳Senegal	MULTI-G	active	—
Omnipaque 300 mg/mL Injection Solution for injection	🇳🇬Nigeria	—	active	—
IOHEXOL-M solution injectable / 350 mg	🇸🇳Senegal	MULTI-G BVBA LEEMSTRAAT 166 2018 ANTWERPEN, BELGIQUE	active	—
Omnipaque 350 mg/mL Injection Solution for injection	🇳🇬Nigeria	—	active	—
IOXRAY 350 MG D’IODE / ML, SOLUTION INJECTABLE, BOÎTE DE 1 FLACON DE 100 ML	🇨🇮Côte d'Ivoire	LABORATOIRES FRILAB S.A.	active	—
OMNIPAQUE solution injectable / 350 mg	🇸🇳Senegal	GE HEALTH CARE	active	—
OMNIPAQUE solution injectable / 300 mg / ml	🇸🇳Senegal	GE HEALTH CARE	active	—
IOHEXO-M injectable / 300mg	🇸🇳Senegal	—	active	—
IOHEXO-M solution injectable / 300mg	🇸🇳Senegal	MULTI-G	active	—
IOXRAY 300 MG D’IODE / ML, SOLUTION INJECTABLE, BOÎTE DE 1 FLACON DE 100 ML	🇨🇮Côte d'Ivoire	LABORATOIRES FRILAB S.A.	active	—
IOHEXO-M injectable / 300mg	🇸🇳Senegal	—	active	—

IOHEXOL in Africa — Regulatory Overview

IOHEXOL is registered across 8 African markets with 41 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Senegal, Ghana and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 41 registrations, 27 (66%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.